Last 12 months
Inside the activity.
0 purchase rows · 40 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 4 |
| Mar 2026 | 0 | 15 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 7 |
| Jun 2026 | 0 | 4 |
| Jul 2026 | 0 | 7 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 22, 2022 Filed Sep 23, 2022 20:16 UTC |
Mehrotra ParthPresident and COO
|
SaleCommon Stock, par value $0.01 per share | 32,342 | $35.10 | $1,135,204.20 |
DisclosureSEC source: 0001759655-22-000134 · wf-form4_166396415687408.xml · nonDerivative · entry 14 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Indirect · By the Parth Mehrotra 2021 Trust Disclosed balance after: 2,817 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2022. F11 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $35.00 to $35.99 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| September 22, 2022 Filed Sep 23, 2022 20:16 UTC |
Mehrotra ParthPresident and COO
|
SaleCommon Stock, par value $0.01 per share | 87,729 | $34.53 | $3,029,282.37 |
DisclosureSEC source: 0001759655-22-000134 · wf-form4_166396415687408.xml · nonDerivative · entry 13 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Indirect · By the Parth Mehrotra 2021 Trust Disclosed balance after: 35,159 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2022. F10 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $34.00 to $34.99 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| September 22, 2022 Filed Sep 23, 2022 20:16 UTC |
Mehrotra ParthPresident and COO
|
Exercise / conversionCommon Stock, par value $0.01 per share | 122,888 | $2.00 | $245,776.00 |
DisclosureSEC source: 0001759655-22-000134 · wf-form4_166396415687408.xml · nonDerivative · entry 12 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Indirect · By the Parth Mehrotra 2021 Trust Disclosed balance after: 122,888 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 22, 2022 Filed Sep 23, 2022 20:16 UTC |
Mehrotra ParthPresident and COO
|
SaleCommon Stock, $0.01 par value per share | 600 | $36.49 | $21,894.00 |
DisclosureSEC source: 0001759655-22-000134 · wf-form4_166396415687408.xml · nonDerivative · entry 11 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,391 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2022. F9 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $36.48 to $36.50 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| September 22, 2022 Filed Sep 23, 2022 20:16 UTC |
Mehrotra ParthPresident and COO
|
SaleCommon Stock, $0.01 par value per share | 40,112 | $35.50 | $1,423,976.00 |
DisclosureSEC source: 0001759655-22-000134 · wf-form4_166396415687408.xml · nonDerivative · entry 10 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,991 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2022. F8 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $35.34 to $36.33 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| September 22, 2022 Filed Sep 23, 2022 20:16 UTC |
Mehrotra ParthPresident and COO
|
SaleCommon Stock, $0.01 par value per share | 170,689 | $38.83 | $6,627,853.87 |
DisclosureSEC source: 0001759655-22-000134 · wf-form4_166396415687408.xml · nonDerivative · entry 9 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,103 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2022. F7 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $34.34 to $35.33 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| September 22, 2022 Filed Sep 23, 2022 20:16 UTC |
Mehrotra ParthPresident and COO
|
SaleCommon Stock, $0.01 par value per share | 60,802 | $33.90 | $2,061,187.80 |
DisclosureSEC source: 0001759655-22-000134 · wf-form4_166396415687408.xml · nonDerivative · entry 8 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 308,792 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2022. F6 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $33.32 to $34.33 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| September 22, 2022 Filed Sep 23, 2022 20:16 UTC |
Mehrotra ParthPresident and COO
|
Exercise / conversionCommon Stock, $0.01 par value per share | 272,203 | $2.00 | $544,406.00 |
DisclosureSEC source: 0001759655-22-000134 · wf-form4_166396415687408.xml · nonDerivative · entry 7 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 369,594 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 22, 2022 Filed Sep 26, 2022 22:32 UTC |
Butler Jeffrey BDirector
|
SaleCommon Stock, $0.01 par value per share | 2,220 | $36.49 | $81,007.80 |
DisclosureSEC source: 0001759655-22-000138 · wf-form4_166423154218441.xml · nonDerivative · entry 5 Butler Jeffrey B · CIK 0001859428 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,319,637 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2022. F6 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $36.32 to $36.90 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| September 22, 2022 Filed Sep 26, 2022 22:32 UTC |
Butler Jeffrey BDirector
|
SaleCommon Stock, $0.01 par value per share | 49,189 | $35.50 | $1,746,209.50 |
DisclosureSEC source: 0001759655-22-000138 · wf-form4_166423154218441.xml · nonDerivative · entry 4 Butler Jeffrey B · CIK 0001859428 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,321,857 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2022. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $35.32 to $36.28 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| September 22, 2022 Filed Sep 26, 2022 22:32 UTC |
Butler Jeffrey BDirector
|
SaleCommon Stock, $0.01 par value per share | 48,049 | $34.95 | $1,679,312.55 |
DisclosureSEC source: 0001759655-22-000138 · wf-form4_166423154218441.xml · nonDerivative · entry 3 Butler Jeffrey B · CIK 0001859428 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,371,046 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2022. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $34.32 to $35.31 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| September 22, 2022 Filed Sep 26, 2022 22:32 UTC |
Butler Jeffrey BDirector
|
SaleCommon Stock, $0.01 par value per share | 40,542 | $33.91 | $1,374,779.22 |
DisclosureSEC source: 0001759655-22-000138 · wf-form4_166423154218441.xml · nonDerivative · entry 2 Butler Jeffrey B · CIK 0001859428 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,419,095 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2022. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $33.32 to $34.30 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| September 21, 2022 Filed Sep 23, 2022 20:16 UTC |
Morris Matthew ShawnDirector · Chief Executive Officer
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 5,985 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001759655-22-000135 · wf-form4_166396418344782.xml · derivative · entry 8 Morris Matthew Shawn · CIK 0001401958 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,657,452 Underlying: Common Stock · 5,985 shares Expires 2033-08-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: Reflects stock options to purchase shares of common stock of the Issuer under the Plan. Prior to the transactions reported in this Form 4, 3,773,347 of the stock options were fully vested and exercisable. 890,090 of the stock options vest on October 29, 2022. Read SEC document |
| September 21, 2022 Filed Sep 23, 2022 20:16 UTC |
Morris Matthew ShawnDirector · Chief Executive Officer
|
SaleCommon Stock, $0.01 par value per share | 557 | $37.63 | $20,959.91 |
DisclosureSEC source: 0001759655-22-000135 · wf-form4_166396418344782.xml · nonDerivative · entry 3 Morris Matthew Shawn · CIK 0001401958 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,739 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 26, 2021, as amended on November 18, 2021. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $37.57 to $37.68 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| September 21, 2022 Filed Sep 23, 2022 20:16 UTC |
Morris Matthew ShawnDirector · Chief Executive Officer
|
SaleCommon Stock, $0.01 par value per share | 5,428 | $37.27 | $202,301.56 |
DisclosureSEC source: 0001759655-22-000135 · wf-form4_166396418344782.xml · nonDerivative · entry 2 Morris Matthew Shawn · CIK 0001401958 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,296 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 26, 2021, as amended on November 18, 2021. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $36.56 to $37.54 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| September 21, 2022 Filed Sep 23, 2022 20:16 UTC |
Morris Matthew ShawnDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock, $0.01 par value per share | 5,985 | $2.00 | $11,970.00 |
DisclosureSEC source: 0001759655-22-000135 · wf-form4_166396418344782.xml · nonDerivative · entry 1 Morris Matthew Shawn · CIK 0001401958 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,724 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 21, 2022 Filed Sep 23, 2022 20:16 UTC |
Mehrotra ParthPresident and COO
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 149,118 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001759655-22-000134 · wf-form4_166396415687408.xml · derivative · entry 17 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Indirect · By the Parth Mehrotra 2021 Trust Disclosed balance after: 122,888 Underlying: Common Stock · 149,118 shares Expires 2034-12-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F14 · derivative.exercise_date: All of the stock options are fully vested and exercisable. Read SEC document |
| September 21, 2022 Filed Sep 23, 2022 20:16 UTC |
Mehrotra ParthPresident and COO
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 122,783 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001759655-22-000134 · wf-form4_166396415687408.xml · derivative · entry 16 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,157,680 Underlying: Common Stock · 122,783 shares Expires 2033-08-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F13 · derivative.exercise_date: Reflects stock options to purchase shares of common stock of the Issuer under the Plan. Prior to the transactions reported in this Form 4, 1,006,904 of the stock options are fully vested and exercisable. 273,559 of the stock options will vest on October 29, 2022. Read SEC document |
| September 21, 2022 Filed Sep 23, 2022 20:16 UTC |
Mehrotra ParthPresident and COO
|
SaleCommon Stock, par value $0.01 per share | 6,524 | $37.66 | $245,693.84 |
DisclosureSEC source: 0001759655-22-000134 · wf-form4_166396415687408.xml · nonDerivative · entry 6 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Indirect · By the Parth Mehrotra 2021 Trust Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2022. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $37.59 to $37.85 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| September 21, 2022 Filed Sep 23, 2022 20:16 UTC |
Mehrotra ParthPresident and COO
|
SaleCommon Stock, par value $0.01 per share | 142,594 | $37.38 | $5,330,163.72 |
DisclosureSEC source: 0001759655-22-000134 · wf-form4_166396415687408.xml · nonDerivative · entry 5 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Indirect · By the Parth Mehrotra 2021 Trust Disclosed balance after: 6,524 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2022. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $36.59 to $37.58 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| September 21, 2022 Filed Sep 23, 2022 20:16 UTC |
Mehrotra ParthPresident and COO
|
Exercise / conversionCommon Stock, par value $0.01 per share | 149,118 | $0.00 | $0.00 |
DisclosureSEC source: 0001759655-22-000134 · wf-form4_166396415687408.xml · nonDerivative · entry 4 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Indirect · By the Parth Mehrotra 2021 Trust Disclosed balance after: 149,118 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 21, 2022 Filed Sep 23, 2022 20:16 UTC |
Mehrotra ParthPresident and COO
|
SaleCommon Stock, $0.01 par value per share | 5,146 | $37.62 | $193,592.52 |
DisclosureSEC source: 0001759655-22-000134 · wf-form4_166396415687408.xml · nonDerivative · entry 3 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,391 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2022. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $37.58 to $37.90 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| September 21, 2022 Filed Sep 23, 2022 20:16 UTC |
Mehrotra ParthPresident and COO
|
SaleCommon Stock, $0.01 par value per share | 117,637 | $37.33 | $4,391,389.21 |
DisclosureSEC source: 0001759655-22-000134 · wf-form4_166396415687408.xml · nonDerivative · entry 2 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,537 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2022. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $36.58 to $37.57 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| September 21, 2022 Filed Sep 23, 2022 20:16 UTC |
Mehrotra ParthPresident and COO
|
Exercise / conversionCommon Stock, $0.01 par value per share | 122,783 | $2.00 | $245,566.00 |
DisclosureSEC source: 0001759655-22-000134 · wf-form4_166396415687408.xml · nonDerivative · entry 1 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 220,174 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 20, 2022 Filed Sep 21, 2022 21:48 UTC |
Mehrotra ParthPresident and COO
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 24,211 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001759655-22-000129 · wf-form4_166379690208402.xml · derivative · entry 24 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Indirect · By the Parth Mehrotra 2021 Trust Disclosed balance after: 0 Underlying: Common Stock · 24,211 shares Expires 2035-09-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F12 · derivative.exercise_date: All of the stock options are fully vested and exercisable. Read SEC document |
| September 20, 2022 Filed Sep 21, 2022 21:48 UTC |
Mehrotra ParthPresident and COO
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 39,494 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001759655-22-000129 · wf-form4_166379690208402.xml · derivative · entry 23 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Indirect · By the Parth Mehrotra 2021 Trust Disclosed balance after: 272,006 Underlying: Common Stock · 39,494 shares Expires 2034-12-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F12 · derivative.exercise_date: All of the stock options are fully vested and exercisable. Read SEC document |
| September 20, 2022 Filed Sep 21, 2022 21:48 UTC |
Mehrotra ParthPresident and COO
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 35,855 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001759655-22-000129 · wf-form4_166379690208402.xml · derivative · entry 22 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 272,577 Underlying: Common Stock · 35,855 shares Expires 2034-12-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · derivative.exercise_date: Reflects stock options to purchase shares of common stock of the Issuer under the Plan. Prior to the transactions reported in this Form 4, 252,395 of the stock options are fully vested and exercisable. 113,066 of the stock options will on October 29, 2022 and 46,446 of the stock options will vest on December 4, 2022. Read SEC document |
| September 20, 2022 Filed Sep 21, 2022 21:48 UTC |
Mehrotra ParthPresident and COO
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 30,156 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001759655-22-000129 · wf-form4_166379690208402.xml · derivative · entry 21 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,280,463 Underlying: Common Stock · 30,156 shares Expires 2033-08-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_date: Reflects stock options to purchase shares of common stock of the Issuer under the Plan. Prior to the transactions reported in this Form 4, 1,072,133 of the stock options are fully vested and exercisable. 273,559 of the stock options will vest on October 29, 2022. Read SEC document |
| September 20, 2022 Filed Sep 21, 2022 21:48 UTC |
Mehrotra ParthPresident and COO
|
SaleCommon Stock, par value $0.01 per share | 63,705 | $37.31 | $2,376,833.55 |
DisclosureSEC source: 0001759655-22-000129 · wf-form4_166379690208402.xml · nonDerivative · entry 16 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Indirect · By the Parth Mehrotra 2021 Trust Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2022. F9 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $36.90 to $37.79 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| September 20, 2022 Filed Sep 21, 2022 21:48 UTC |
Mehrotra ParthPresident and COO
|
Exercise / conversionCommon Stock, par value $0.01 per share | 24,211 | $2.00 | $48,422.00 |
DisclosureSEC source: 0001759655-22-000129 · wf-form4_166379690208402.xml · nonDerivative · entry 15 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Indirect · By the Parth Mehrotra 2021 Trust Disclosed balance after: 63,705 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 20, 2022 Filed Sep 21, 2022 21:48 UTC |
Mehrotra ParthPresident and COO
|
Exercise / conversionCommon Stock, par value $0.01 per share | 39,494 | $2.00 | $78,988.00 |
DisclosureSEC source: 0001759655-22-000129 · wf-form4_166379690208402.xml · nonDerivative · entry 14 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Indirect · By the Parth Mehrotra 2021 Trust Disclosed balance after: 39,494 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 20, 2022 Filed Sep 21, 2022 21:48 UTC |
Mehrotra ParthPresident and COO
|
SaleCommon Stock, $0.01 par value per share | 66,011 | $37.30 | $2,462,210.30 |
DisclosureSEC source: 0001759655-22-000129 · wf-form4_166379690208402.xml · nonDerivative · entry 13 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,391 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2022. F8 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $36.89 to $37.79 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| September 20, 2022 Filed Sep 21, 2022 21:48 UTC |
Mehrotra ParthPresident and COO
|
Exercise / conversionCommon Stock, par value $0.01 per share | 35,855 | $2.00 | $71,710.00 |
DisclosureSEC source: 0001759655-22-000129 · wf-form4_166379690208402.xml · nonDerivative · entry 12 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,402 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 20, 2022 Filed Sep 21, 2022 21:48 UTC |
Mehrotra ParthPresident and COO
|
Exercise / conversionCommon Stock, par value $0.01 per share | 30,156 | $2.00 | $60,312.00 |
DisclosureSEC source: 0001759655-22-000129 · wf-form4_166379690208402.xml · nonDerivative · entry 11 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,547 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 19, 2022 Filed Sep 21, 2022 21:48 UTC |
Mehrotra ParthPresident and COO
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 80,005 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001759655-22-000129 · wf-form4_166379690208402.xml · derivative · entry 20 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Indirect · By the Parth Mehrotra 2021 Trust Disclosed balance after: 24,211 Underlying: Common Stock · 80,005 shares Expires 2035-09-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F12 · derivative.exercise_date: All of the stock options are fully vested and exercisable. Read SEC document |
| September 19, 2022 Filed Sep 21, 2022 21:48 UTC |
Mehrotra ParthPresident and COO
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 27,697 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001759655-22-000129 · wf-form4_166379690208402.xml · derivative · entry 19 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Indirect · By the Parth Mehrotra 2021 Trust Disclosed balance after: 311,500 Underlying: Common Stock · 27,697 shares Expires 2034-12-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F12 · derivative.exercise_date: All of the stock options are fully vested and exercisable. Read SEC document |
| September 19, 2022 Filed Sep 21, 2022 21:48 UTC |
Mehrotra ParthPresident and COO
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 103,474 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001759655-22-000129 · wf-form4_166379690208402.xml · derivative · entry 18 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 308,432 Underlying: Common Stock · 103,474 shares Expires 2034-12-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · derivative.exercise_date: Reflects stock options to purchase shares of common stock of the Issuer under the Plan. Prior to the transactions reported in this Form 4, 252,395 of the stock options are fully vested and exercisable. 113,066 of the stock options will on October 29, 2022 and 46,446 of the stock options will vest on December 4, 2022. Read SEC document |
| September 19, 2022 Filed Sep 21, 2022 21:48 UTC |
Mehrotra ParthPresident and COO
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 35,073 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001759655-22-000129 · wf-form4_166379690208402.xml · derivative · entry 17 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,310,619 Underlying: Common Stock · 35,073 shares Expires 2033-08-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_date: Reflects stock options to purchase shares of common stock of the Issuer under the Plan. Prior to the transactions reported in this Form 4, 1,072,133 of the stock options are fully vested and exercisable. 273,559 of the stock options will vest on October 29, 2022. Read SEC document |
| September 19, 2022 Filed Sep 21, 2022 21:48 UTC |
Mehrotra ParthPresident and COO
|
SaleCommon Stock, par value $0.01 per share | 2,540 | $38.89 | $98,780.60 |
DisclosureSEC source: 0001759655-22-000129 · wf-form4_166379690208402.xml · nonDerivative · entry 10 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Indirect · By the Parth Mehrotra 2021 Trust Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2022. F7 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $38.79 to $39.05 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| September 19, 2022 Filed Sep 21, 2022 21:48 UTC |
Mehrotra ParthPresident and COO
|
SaleCommon Stock, par value $0.01 per share | 67,720 | $37.96 | $2,570,651.20 |
DisclosureSEC source: 0001759655-22-000129 · wf-form4_166379690208402.xml · nonDerivative · entry 9 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Indirect · By the Parth Mehrotra 2021 Trust Disclosed balance after: 2,540 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2022. F6 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $37.78 to $38.77 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| September 19, 2022 Filed Sep 21, 2022 21:48 UTC |
Mehrotra ParthPresident and COO
|
SaleCommon Stock, par value $0.01 per share | 37,442 | $37.48 | $1,403,326.16 |
DisclosureSEC source: 0001759655-22-000129 · wf-form4_166379690208402.xml · nonDerivative · entry 8 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Indirect · By the Parth Mehrotra 2021 Trust Disclosed balance after: 70,260 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2022. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $36.78 to $37.77 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| September 19, 2022 Filed Sep 21, 2022 21:48 UTC |
Mehrotra ParthPresident and COO
|
Exercise / conversionCommon Stock, par value $0.01 per share | 80,005 | $2.00 | $160,010.00 |
DisclosureSEC source: 0001759655-22-000129 · wf-form4_166379690208402.xml · nonDerivative · entry 7 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Indirect · By the Parth Mehrotra 2021 Trust Disclosed balance after: 107,702 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 19, 2022 Filed Sep 21, 2022 21:48 UTC |
Mehrotra ParthPresident and COO
|
Exercise / conversionCommon Stock, par value $0.01 per share | 27,697 | $2.00 | $55,394.00 |
DisclosureSEC source: 0001759655-22-000129 · wf-form4_166379690208402.xml · nonDerivative · entry 6 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Indirect · By the Parth Mehrotra 2021 Trust Disclosed balance after: 27,697 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 19, 2022 Filed Sep 21, 2022 21:48 UTC |
Mehrotra ParthPresident and COO
|
SaleCommon Stock, par value $0.01 per share | 2,230 | $38.94 | $86,836.20 |
DisclosureSEC source: 0001759655-22-000129 · wf-form4_166379690208402.xml · nonDerivative · entry 5 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,391 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2022. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $38.82 to $39.12 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| September 19, 2022 Filed Sep 21, 2022 21:48 UTC |
Mehrotra ParthPresident and COO
|
SaleCommon Stock, par value $0.01 per share | 60,700 | $38.10 | $2,312,670.00 |
DisclosureSEC source: 0001759655-22-000129 · wf-form4_166379690208402.xml · nonDerivative · entry 4 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,621 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2022. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $37.82 to $38.79 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| September 19, 2022 Filed Sep 21, 2022 21:48 UTC |
Mehrotra ParthPresident and COO
|
SaleCommon Stock, par value $0.01 per share | 75,617 | $37.60 | $2,843,199.20 |
DisclosureSEC source: 0001759655-22-000129 · wf-form4_166379690208402.xml · nonDerivative · entry 3 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,321 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2022. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $36.82 to $37.81 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| September 19, 2022 Filed Sep 21, 2022 21:48 UTC |
Mehrotra ParthPresident and COO
|
Exercise / conversionCommon Stock, par value $0.01 per share | 103,474 | $2.00 | $206,948.00 |
DisclosureSEC source: 0001759655-22-000129 · wf-form4_166379690208402.xml · nonDerivative · entry 2 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 235,938 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 19, 2022 Filed Sep 21, 2022 21:48 UTC |
Mehrotra ParthPresident and COO
|
Exercise / conversionCommon Stock, par value $0.01 per share | 35,073 | $2.00 | $70,146.00 |
DisclosureSEC source: 0001759655-22-000129 · wf-form4_166379690208402.xml · nonDerivative · entry 1 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,464 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 07, 2022 Filed Sep 8, 2022 20:06 UTC |
Morris Matthew ShawnDirector · Chief Executive Officer
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 34,615 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001759655-22-000125 · wf-form4_166266755859455.xml · derivative · entry 8 Morris Matthew Shawn · CIK 0001401958 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,663,437 Underlying: Common Stock · 34,615 shares Expires 2033-08-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: Reflects stock options to purchase shares of common stock of the Issuer under the Plan. Prior to the transactions reported in this Form 4, 3,839,197 of the stock options were fully vested and exercisable.890,090 of the stock options vest on October 29, 2022 Read SEC document |
| September 07, 2022 Filed Sep 8, 2022 20:06 UTC |
Morris Matthew ShawnDirector · Chief Executive Officer
|
SaleCommon Stock, $0.01 par value per share | 20,043 | $40.17 | $805,127.31 |
DisclosureSEC source: 0001759655-22-000125 · wf-form4_166266755859455.xml · nonDerivative · entry 6 Morris Matthew Shawn · CIK 0001401958 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,739 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 26, 2021, as amended on November 18, 2021. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $39.83 to $40.59 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.